Valeant Selling iNova to Private Equity for $930 Million

15.06.2017 - Canada-based, US-run drugmaker Valeant has agreed to sell its iNova Pharmaceuticals subsidiary for $930 million in cash to a company jointly owned by funds advised and managed by...